BRD4 and leukemia: To further demonstrate the site-specific role of proline hydroxylation on leukemia cell activity, we generated a Brd4 mutant plasmid with P536A through site-directed mutagenesis and identified an shRNA targeting 3′UTR to knock down the endogenous Brd4 (Figure 5G).